Clinical Trials Directory

Trials / Terminated

TerminatedNCT00209131

Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.

Detailed description

Placebo blinded study examining the effects of Flomax on stone passage rates following SWL.

Conditions

Interventions

TypeNameDescription
DRUGFlomax0.4mg Flomax pills will be given to patients to take once daily for one month following shock wave lithotripsy to aid the stone passage.
DRUGSugar pillComparable sugar pills will be given to the placebo group to take daily for one month following shock wave lithotripsy to aid stone passage.

Timeline

Start date
2005-04-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2005-09-21
Last updated
2013-10-28
Results posted
2012-07-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00209131. Inclusion in this directory is not an endorsement.